Abstract
The proposed 2020 Core Curriculum for Percutaneous Cardiovascular Interventions aims to provide an updated European consensus that defines the level of experience and knowledge in the field of percutaneous cardiovascular intervention (PCI). It promotes homogenous education and training programmes among countries, and is the cornerstone of the new EAPCI certification, designed to support the recognition of competencies at the European level and the free movement of certified specialists in the European Community. It is based on a thorough review of the ESC guidelines and of the EAPCI textbook on percutaneous interventional cardiovascular medicine. The structure of the current core curriculum evolved from previous EAPCI core curricula and from the “2013 core curriculum of the general cardiologist” to follow the current ESC recommendations for core curricula. In most subject areas, there was a wide - if not unanimous - consensus among the task force members on the training required for the interventional cardiologist of the future. The document recommends that acquisition of competence in interventional cardiology requires at least two years of postgraduate training, in addition to four years devoted to cardiology. The first part of the curriculum covers general aspects of training and is followed by a comprehensive description of the specific components in 54 chapters. Each of the chapters includes statements of the objectives, and is further subdivided into the required knowledge, skills, behaviours, and attitudes.
Introduction
The present version of the Core Curriculum for Percutaneous Cardiovascular Interventions was organised and developed by the Education and Training Committee (ETC) of the European Association of Percutaneous Coronary Interventions (EAPCI), under the leadership of EAPCI Presidents Michael Haude and Andreas Baumbach.
In most countries, the prevalence of coronary artery disease (CAD), valvular heart disease (VHD), peripheral vascular disease (PVD) and heart failure (HF) is increasing. This relates both to the progressive ageing of the population and to a better identification of these diseases. To date, cardiovascular disease remains the leading cause of death worldwide. In Europe, ischaemic heart disease now accounts for almost 1.8 million annual deaths while VHD is becoming a pressing clinical issue1,2.
The main areas of the percutaneous cardiovascular interventional field, as covered by the interventional cardiologist (IC), are percutaneous coronary interventions (PCI), transcatheter valvular interventions, percutaneous interventions for PVD (including those for ischaemic stroke), and percutaneous interventions for HF (including those for cardiogenic shock).
The broad use of these interventions is supported by overriding scientific evidence and has been associated with durable benefits for both individuals and populations3,4,5,6,7,8,9,10,11,12. In this context, ensuring quality of patient care, and clinical excellence in percutaneous cardiovascular interventions are of the utmost importance. The completion of a dedicated curriculum provides the IC with the knowledge, skills, behaviours and attitudes to act as an expert in the invasive physiological and anatomic assessment, diagnosis, and management of coronary and structural heart diseases as well as in the invasive management of HF and PVD.
The first and only “Curriculum and syllabus for Interventional Cardiology subspecialty training in Europe” was published in 2006 by di Mario et al on behalf of the “Working Group 10 of the ESC” (which later became the EAPCI) and a panel of experts in education including the chairmen of the national interventional societies, coordinated by the European Board for the Specialty of Cardiology (EBSC)13. This document was very ambitious and addressed the need for a certified, uniform, training programme, before cardiologists engage in interventional procedures that carry a potential risk. It was divided into several parts: rationale and aims of the curriculum, structure of the training programme, assessment methods, organisation of the training and, importantly, a syllabus-specific programme content with several chapters (basic science, pharmacology, imaging, indication for treatment and patient selection, procedural techniques, management of complications of percutaneous intervention and miscellaneous). Some procedures were not considered to be part of the core curriculum but rather an “optional” part of the training.
The 2006 visionary document set the European standards although these were not broadly adopted. The present approach intends to overcome the main limitations identified in the previous document, namely its endorsement and promotion by the interventional and general cardiology societies. The proposed core curriculum aims to support the educational requirements and to fill the gap of an updated European consensus that defines the level of competences in the field of percutaneous cardiovascular intervention. It promotes homogenous education and training programmes in interventional cardiology among countries, and is the cornerstone of the new EAPCI certification, designed to support the recognition of knowledge, skills, behaviours and attitudes of newly trained interventional cardiologists.
Considering the distinct realities among European and other countries and because numbers are not sufficient per se to describe the proficiency of an IC, the present document is not recommending minimal procedural volume for trainees or for training centres. It is rather providing guidance on the “achievements” and on the “levels of competence” which have to be acquired by the trainees (Table 1-Table 3). We also provide detailed information on how a training centre will have to be organised, including the need to involve at least two ICs with more than five years’ experience dedicated to the percutaneous cardiovascular interventional field (Table 4).
Table 1. Summary of the general aspects of training in interventional cardiology.
Area of training | General aspects of training |
Continuous medical education | Structured learning under supervision, including explicit learning and implicit learning. |
Supervision and mentoring | Acute and elective cases with direct supervision, progressing from second, to first and ultimately independent operator status. |
Research | Participation in clinical/translational research to enhance critical appraisal of evidence. |
Evaluation | Clearly defined for each individual, with regular review/appraisal of their progress and formal assessment. |
Out-patient care | Preprocedural and post-procedural assessment. |
Acute coronary syndrome, STEMI | Appropriate mix of in-patient/emergency and out-patient/elective care, including patients with “acute coronary syndrome” and “out-of-hospital cardiac arrest”. |
Percutaneous coronary interventions | Experience with different arterial accesses and exposure to several complex techniques. |
Structural interventions | Exposure to structural intervention is strongly recommended. |
Heart Team | Regular participation in the Heart Team meetings. |
Table 3. Level of competence translating into interventional cardiology skills.
Technique | Description of competence | Level of competence |
Peripheral venous access | Performance as first operator and teaching/supervision to more junior colleagues | V |
Radial access | Performance as first operator and teaching/supervision to more junior colleagues | V |
Femoral access <10 Fr | Performance as first operator and teaching/supervision to more junior colleagues | V |
Femoral access ≥10 Fr | Performance with reactive supervision, i.e., on request and quickly available | III |
Closure devices <9 Fr | Performance as first operator and teaching/supervision to more junior colleagues | V |
Closure devices ≥9 Fr | Performance with reactive supervision, i.e., on request and quickly available | III |
Pericardiocentesis | Performance as first operator without supervision | IV |
Right and left haemodynamic assessment | Performance as first operator and teaching/supervision to more junior colleagues | V |
Coronary angiography | Performance as first operator and teaching/supervision to more junior colleagues | V |
Ventricular angiography | Performance as first operator and teaching/supervision to more junior colleagues | V |
Peripheral angiography | Performance with reactive supervision, i.e., on request and quickly available | III |
Cerebral angiography | No performance, even with direct supervision. Observation is recommended | I |
PCI in simple lesions | Performance as first operator without supervision | IV |
PCI in STEMI | Performance as first operator without supervision | IV |
PCI in NSTE-ACS | Performance as first operator without supervision | IV |
PCI in multivessel disease | Performance as first operator without supervision | IV |
PCI in bypass grafts | Performance as first operator without supervision | IV |
PCI in bifurcation lesions | Performance as first operator without supervision | IV |
PCI in LM | Performance as first operator without supervision | IV |
PCI in CTO | Performance as second operator and/or with direct, proactive supervision | II |
PCI with rotablator | Performance as second operator and/or with direct, proactive supervision | II |
Invasive physiology (FFR, iFR, RFR and others) | Performance as first operator without supervision | IV |
OCT/OFDI | Supervision at a distance and/or post hoc | IV |
IVUS | Supervision at a distance and/or post hoc | IV |
Endomyocardial biopsy | No performance, even with direct supervision. Observation is recommended | I |
Use of percutaneous mechanical haemodynamic support | Performance with reactive supervision, i.e., on request and quickly available | III |
Balloon aortic valvuloplasty | Performance as second operator and/or with direct, proactive supervision | II |
TAVI | Performance as second operator and/or with direct, proactive supervision | II |
Balloon mitral valvuloplasty | Performance as second operator and/or with direct, proactive supervision | II |
Transcatheter mitral valve repair | No performance, even with direct supervision. Observation is recommended | I |
Transcatheter mitral valve implantation | No performance, even with direct supervision. Observation is recommended | I |
Transcoronary ablation of septal hypertrophy | No performance, even with direct supervision. Observation is recommended | I |
Transcatheter pulmonary valve interventions | No performance, even with direct supervision. Observation is recommended | I |
Left atrial appendage occlusion | Performance as second operator and/or with direct, proactive supervision | II |
Atrial septal defect closure or patent foramen ovale closure | Performance as second operator and/or with direct, proactive supervision | II |
Closure of ventricular septal defect | No performance, even with direct supervision. Observation is recommended | I |
Percutaneous treatment of paravalvular leaks | No performance, even with direct supervision. Observation is recommended | I |
Transcatheter myocardial stem cell therapy | No performance, even with direct supervision. Observation is recommended | I |
Cardiac catheterisation in “grown-up congenital heart” patients | Performance as second operator and/or with direct, proactive supervision | II |
Supra-aortic interventions including acute ischaemic stroke treatment | No performance, even with direct supervision. Observation is recommended | I |
Aortic disease interventions (thoracic endovascular repair of aorta/endovascular repair of aortic aneurysm) | No performance, even with direct supervision. Observation is recommended | I |
Infra-aortic arterial disease interventions | No performance, even with direct supervision. Observation is recommended | I |
Renovascular interventions for arterial hypertension | No performance, even with direct supervision. Observation is recommended | I |
Transseptal puncture | Performance as second operator and/or with direct, proactive supervision | II |
Interpretation of multislice CT for TAVI | Performance as second operator and/or with direct, proactive supervision | II |
Interpretation of transoesophageal echocardiography for mitral procedure | Performance as second operator and/or with direct, proactive supervision | II |
Percutaneous direct treatment for acute pulmonary embolism | No performance, even with direct supervision. Observation is recommended | I |
Balloon pulmonary angioplasty for “chronic thromboembolic pulmonary hypertension” | No performance, even with direct supervision. Observation is recommended | I |
Table 4. Characteristics and requirements of training centres.
Basic characteristics(mandatory) | – Number of trainees should not exceed number of trainers – Catheterisation laboratory conferences, at least monthly – Regular electronic database, audited by the national interventional association/working group<br /> – Research programme – Performance measures at least annually – Quality programme – Radiation safety programme – Compliance with local standards according to national regulation bodies, including minimal procedural volumes |
Standard centre | – PCI including complex procedures (mandatory) – Intracoronary imaging (IVUS and/or OCT, others) and invasive physiological assessment (FFR, iFR, RFR and others) (mandatory) – CTO programme (recommended) – Rotational atherectomy (recommended) – Percutaneous mechanical circulatory support devices (encouraged) – TAVI (encouraged) |
Advanced centre | – PCI including complex procedures (mandatory) – Intracoronary imaging (IVUS and/or OCT, others) and invasive physiological assessment (FFR, iFR, RFR and others) (mandatory) – CTO programme (mandatory) – Rotational atherectomy and lithotripsy (mandatory) – Percutaneous mechanical circulatory support device programme (recommended) – TAVI (mandatory) – Transseptal procedures (mandatory) – Other structural procedures (recommended) |
The EAPCI has designed a new two-part certification process: part A (theoretical) and part B (practical). Part A is a multiple choice question (MCQ) exam held twice a year, based on the present core curriculum, as well as the EAPCI Textbook of Interventional Cardiology, the ESC General Cardiology Core Curriculum and the content of the Fellows Course of the EAPCI. The exam was successfully launched at EuroPCR 2018 in Paris. Part B, which is currently under final development, is based on the recognition of acquisition of the competencies listed in Table 4 of the present document. To prevent duplication, and simplify the process, it will preferably be conducted through a very strong interaction with national certification programmes when such programmes exist (i.e., mutual recognition process) and/or a direct interaction with training centres. The model of the present EAPCI certification, in which full certification requires acquiring the two parts, is very similar to those developed by the other subspecialty associations of the European Society of Cardiology (ESC).
The EAPCI ETC Committee launched the project under the auspices of Professors Michael Haude and Andreas Baumbach. A total of 10 groups, consisting of two to three interventional cardiologists each, developed, circulated and improved the document under the direction of the successive Chair and Co-Chair of the ETC, Professors Dariusz Dudek and Eric Van Belle and Doctor Rui Campante Teles. The document was revised by the Chair and Co-Chair of the ETC, Professor Eric Van Belle and Doctor Rui Campante Teles, as well as the current EAPCI President, Professor Andreas Baumbach, and President Elect, Professor Dariusz Dudek.
The 2020 Core Curriculum underwent a thorough review process based on the template of the review of the ESC guidelines and of the EAPCI textbook on percutaneous interventional cardiovascular medicine. The document does not include minimum or optimal numbers of procedures to be undertaken, and does not address periodic evaluation or revalidation. It defines the clinical, patient-oriented, training of the IC. The structure of the current core curriculum has been drastically modified as compared to the previous version and has evolved from the “2013 Core Curriculum of the general cardiologist” to follow the current ESC recommendations for core curriculums. In most subject areas, there was a wide if not unanimous consensus among the task force members on the training required for the IC of the future. The document recommends that acquisition of competence requires at least two years of training in interventional cardiology, in addition to four years devoted to cardiology.
The first part of the curriculum covers general aspects of training and is followed by a comprehensive description of the specific components in 54 chapters. Each of the chapters includes statements of the objectives, and is further subdivided into the required knowledge, skills, behaviours, and attitudes.
The core curriculum for the interventional cardiologist
THE CLINICAL FIELD OF INTERVENTIONAL CARDIOLOGY
The clinical specialty of interventional cardiology aims to deliver expert interventional care for patients presenting with disorders of the heart, the systemic, and the pulmonary circulations. This core curriculum provides the standards for training in interventional cardiology, as well as a template for the maintenance of competence for qualified cardiologists.
The IC is the subspecialist who performs percutaneous interventional cardiovascular procedures. He/she is primarily a medical specialist with a thorough basic training in internal medicine who has completed an approved cardiology fellowship programme incorporating the knowledge demanded by the ESC Core Curriculum for the general cardiologist14. Interventional cardiologists perform general cardiac investigation and management of patients with suspected or established cardiovascular disease using non-invasive methods and are involved in the comprehensive management of the patient and treatment of the underlying disease, not only focused on procedural considerations. They have the ability to consider and apply interventional techniques to the global care of patients. They are team workers who interact closely with other cardiologists and other medical specialties, nurses, paramedics and other healthcare professionals.
In order to master the invasive techniques, there are skills in several general fields which are important for the IC and require special differentiation that complement basic general cardiology skills. It is recommended that an operator be able to interpret the most advanced cardiology imaging techniques required for periprocedural assessment, especially echocardiography, computed tomography and endovascular studies. A high level of cardiac intensive care experience is requested, with a special emphasis on acute heart failure and arrhythmia management14.
As simulators have shown benefit in the progress of novice operators, they are progressively being incorporated into training programmes and courses15,16. While the exact role of these simulators in most advanced technical skills still needs to be clarified, with their progressive sophistication their use in the training of ICs will continue to increase.
A key role of the IC is to perform emergency procedures for reperfusion of acute myocardial infarction in 24/7 PCI-capable centres. Regarding PCI, any operator is expected to be fully competent regarding the entire spectrum of patient evaluation, information, techniques and follow-up, including all advanced techniques such as imaging, physiology, adverse clinical presentations and anatomies and adverse lesion scenarios, incorporating calcification, degenerated grafts, simple chronic total occlusions (CTOs) and bifurcations in general. An IC is expected to be fully skilled in the management of any procedural complications.
Concerning the increasing importance of transcatheter aortic valve implantation (TAVI), any operator should be prepared to conduct complete preprocedural evaluation of TAVI candidates and collaborate with a valvular Heart Team to select the most suitable treatment.
Concomitantly, these fields are continuously expanding and, in certain cases, a very specific training to master a procedure or technique is required. Help from a proctor is recognised as advantageous or an appropriate referral to a more skilled centre might be advisable, especially in certain areas that, depending on the individual and the centre, require a particular expertise, namely complex coronary interventions, stroke, PVD, grown-up congenital heart (GUCH) disease, mitral or tricuspid valve disease, left atrial appendage occlusion (LAAO), etc.
The spectrum of expertise is broad and, in addition to the procedures, includes a comprehensive patient risk assessment that is fundamental for patient information and integrates medical decision making. A multidisciplinary management strategy is essential including a heart failure specialist, imaging specialist, surgeons, geriatrician, anaesthetist and cardiac rhythm specialists17.
Because these interventions are applied to a very large population of patients, their economic impact has become significant. The IC must be conscious of this economic burden and responsible for the appropriate utilisation of devices and therapies.
The process for medical decision making and patient information is guided by the “four principles” approach to healthcare ethics - autonomy, beneficence, non-maleficence and justice. The IC represents the patient’s best interest and therefore the medical decision process must be independent and be performed according to the best available evidence, in order to deliver optimal patient-centred care. Moreover, because this is a very technological and continuously demanding evolving medical area, it requires lifelong learning and continuous updating of his/her knowledge. The IC is expected to be engaged in structured clinical investigation programmes and to collaborate actively in patient follow-up.
GENERAL ASPECTS OF TRAINING IN THE SPECIALTY
Candidates for interventional training should be physicians licensed to practise in the country of training. The trainee must have the necessary linguistic ability to communicate with patients and colleagues in the country of training and later in the country of practice. The trainee should have completed a minimum of four years of full-time training in general cardiology.
The recommended minimum duration of dedicated subspeciality training should be two years of full-time and exclusive training in interventional cardiology.
To gain sufficient experience, the trainee should gain exposure to all aspects of interventional cardiology, with an appropriate mix of in-patient/out-patient and emergency/elective care, including the elements described below and summarised in Table 1:
– Participation in the clinical management of in-patients, with an emphasis on patients presenting acutely to the coronary care unit (CCU) and acute medical unit (AMU) with acute coronary syndromes (ACS).
– Regular on-call commitment providing a primary PCI service for patients presenting with ST-elevation myocardial infarction (STEMI) and/or out-of-hospital cardiac arrest (OHCA).
– Regular attendance and/or coordination of Heart Team meetings.
– Bedside patient care, including preprocedural and post-procedural assessment.
– Structured learning, under the direct supervision of educational supervisors/nominated trainers, which may include (a minimum of two hours/day is suggested):
– explicit learning: journal club, postgraduate teaching, exercises in evidence-based medicine, discussion of guidelines for clinical practice, national/international symposia/congress attendance.
– implicit learning: ward rounds, case-based discussions, supervised acquisition of diagnostic and interventional skills.
– Interventional training should include a mix of acute and elective cases with direct supervision, progressing from second, to first and ultimately independent operator status by the end of the training period.
– Interventional training should guarantee experience with arterial access (femoral and radial), and with the most frequent of the complex techniques, including bifurcation strategies, treatment of calcified vessels, intravascular imaging, and functional assessment of coronary stenoses (FFR, iFR, etc.).
– Exposure to chronic total occlusion (CTO) strategies, with both antegrade and retrograde approach, atherectomy techniques including rotablation, haemodynamic support/mechanical circulatory support, is required.
– Exposure to structural intervention including TAVI, mitral and tricuspid valve treatment, atrial septal defect/patent foramen ovale/left atrial appendage closure, and paravalvular leak/ventricular septal defect closure is strongly recommended.
– The training programme should be clearly defined for each individual, with regular review/appraisal of their progress and formal assessment of their knowledge and procedural competencies.
– Participation in clinical/translational research in interventional cardiology is recommended to enhance critical appraisal of evidence.
Learning objectives should be clearly defined and are preferred to recommendations based solely on the time spent in a particular department or on the number of procedures performed. The objectives should include knowledge, and specific and generic skills including communication and appropriate behaviours, competencies and attitudes that will be further reinforced during ongoing training.
LEARNING OBJECTIVES
These are specific aims which demonstrate skills acquired by the trainee at the end of the course. They are based on the trainee’s capabilities in certain tasks. Specific objectives are classified according to knowledge, skills, and behaviours and attitudes.
– Knowledge: describes requirements for trainees. The subject matter is defined by the EAPCI Core Curriculum chapters. This knowledge includes pathology of diseases as the rational basis for long-term learning.
– Skills: a practical application of knowledge acquired from experience and training to solve practical problems, make clinical decisions and perform specific procedures.
– Behaviours and attitudes: refer to those attitudes and behaviours that lead to optimal clinical performance.
CATEGORIES AND LEVELS OF COMPETENCE
First-hand exposure and practical experience are crucial in the learning of techniques. However, the number of procedures performed by trainees is not considered an exclusive measure of performance. The authors acknowledge the variability of the learning curve among individuals and the impact of the training centre volumes on the learning process. Thus, this document focuses on the acquisition of competencies rather than on procedural volume.
This section describes the levels to translate competencies into investigational or procedural skills. Their ascending order is defined as follows and summarised in Table 2. It has been adapted from the description of Entrustable Professional Activities (EPA)18:
Table 2. Description of levels translating competence into investigational or procedural skills (adapted from EPA).
Technique | Description of competence |
Level I* | No performance, even with direct supervision. Observation is recommended |
Level II* | Performance as second operator and/or with direct, proactive supervision |
Level III | Performance as first operator with reactive supervision, i.e., on request and quickly available |
Level IV | Performance as first operator without supervision. Possibility of post hoc supervision. |
Level V** | Performance as first operator without supervision and ability to teach/supervise more junior colleagues |
* Level I and II intervention skills may be acquired outside the primary training centre, as part of a cooperation programme. ** Level V intervention skills are not expected in all areas at the end of the two years of training in interventional cardiology. |
– Levels I and II. The trainee must have acquired experience in selecting an appropriate diagnosis or therapy and in interpreting results or choosing an appropriate treatment for a referred patient.
– Level I does not require any procedural skills, yet participation in related procedures during training may be valuable.
– Level II of competency indicates acquisition of some procedural skills as operator, usually as assistant/second operator, obtained in the primary or external training centres.
– Level III. The trainee must be able to interpret clinical data, recognise treatment indications, and perform the technique or procedure and manage related complications, as first operator, but still requires to work under the direct supervision of a senior IC operator.
– Level IV. The trainee must be independent in the ability to interpret clinical data, recognise treatment indications, perform the technique or procedure and manage related complications, as first operator without the direct supervision of a senior IC operator. Post hoc supervision including case review with more senior colleagues is possible.
– Level V. Same as level IV. In addition, it includes the ability to teach and supervise the technique or procedure to more junior colleagues.
Table 3 summarises the level of competence translating into interventional cardiology skills that the EAPCI considers desirable for a trainee in interventional cardiology to achieve at the end of his/her two years of training19,20,21,22,23,24. Although organisation of cardiac services and resources for training are not uniform across Europe and ESC member countries, the core curriculum aspires to an optimal, rather than a minimal standard. In countries or centres that are currently unable to deliver training in all aspects required, the core curriculum should be used as a benchmark to promote policies for improvement. Also, rotation of trainees between different centres may provide an adequate solution.
REQUIREMENTS FOR TRAINING INSTITUTIONS AND TRAINERS
REQUIREMENTS FOR TRAINING INSTITUTIONS
General aspects
We believe that training institution profile and performance are as important as trainers’ profile and expertise in order to provide objective and quality interventional training. In order to comply with EAPCI standards, the institutions must be standardised using procedural volume reports and performance measures.
A training institution/centre for interventional cardiology should include a cardiac catheterisation laboratory with on-call 24-hour PCI availability and a dedicated cardiology unit, department or ward, in order to manage patients throughout hospitalisation. The trainee should be able to be educated to manage patients from their admission, through the invasive procedure, to discharge from the ward. Institutional workflow allowing the interventional cardiology programme attendees to follow the patient throughout their hospitalisation is mandatory.
The training centre should have an independent interventional cardiology unit, allowing the trainee to follow the patient from the beginning to the completion of interventional treatment. Units not integrated into a cardiology department (run as a service without dedicated beds) can exceptionally be considered if they demonstrate a well-developed structured co-operation with cardiology wards where the patients are admitted, allowing the interventional cardiology programme attendees to follow the patient throughout their hospitalisation.
Training centres should be encouraged to incorporate on-site interventional cardiology simulators or to provide simulation sessions during the IC training, especially during the early phases of training of the trainee and/or the techniques15,16.
Training centres should have the following basic characteristics (summarised in Table 4):
1) Active clinical research programme and/or involvement in clinical trials is mandatory for both types of centre.
2) Number of trainees per institution should not exceed the number of faculty members/trainers.
3) Heart Team meetings, including participation by clinical cardiologists, interventional operators, and cardiothoracic surgeons should be planned regularly (i.e., weekly or bimonthly).
4) Regular database - electronic database of diagnostic and interventional procedures regularly audited by the national interventional society is recommended to ensure centre quality.
5) Performance measures report of the institution (periodic, at least annual): in-hospital mortality in acute, elective PCI and diagnostic catheterisation.
6) Regular “quality assessment and quality improvement” (QA/QI) programme including radiation safety programme.
We further define two types of training centre: standard and advanced training centre (Table 4).
– Standard centre: must have a (mandatory) programme of 24 hours a day availability of PCI on call for STEMI/NSTEMI patients and a working hours regular programme for all kinds of patients. Availability of IVUS and/or OCT and assessment of intracoronary pressure-based physiology indices such as FFR/iFR is mandatory. It is strongly recommended that these centres are involved in complex PCI, including left main and multivessel disease. Availability of left ventricular assist devices such as IABP/Impella™ (Abiomed, Danvers, MA, USA) is desirable but not mandatory as well as a CTO programme, rotational atherectomy and similar procedures. Institutional coronary and structural Heart Teams are also encouraged, even if the centre does not perform TAVI.
– Advanced centres: these have similar requirements to standard centres and should have a structural heart programme including at least TAVI according to national regulation, transseptal procedures and a structured CTO programme. Other structural procedures (stroke, carotid, peripheral, GUCH, septal ablation, left atrial appendage occlusion, paravalvular leak closure, etc.) are recommended. The presence of a Heart Team is mandatory.
– A centre may develop other programmes for peripheral interventions (stroke, carotid stenting, aorta, peripheral limb), treatment of adult congenital heart disease, performance of septal ablation for hypertrophic cardiomyopathy, etc.
Procedural volumes and public metric reporting
It has been established that the procedural volumes of centres have a significant impact on the availability of training opportunities and on performance measures and intervention outcomes, but numbers are insufficient to define the quality of a centre and their ability to train interventional fellows. Public reporting of centre training programmes, procedural volumes and clinical outcomes is advisable to guide trainee choice of the training centre. While the present document does not make recommendations on specific procedural volumes, training centres should comply with local standards according to national regulation bodies, including minimal procedural volumes.
REQUIREMENTS FOR TRAINERS
General aspects and levels of competence
Trainers should be graded as trainers in standard institutions (standard trainers) and trainers in advanced institutions (advanced trainers). Trainers should be experts for levels of competence III, IV and V (Table 2, Table 3). It is not required that every trainer be expert in those techniques for which a level of competence I or II (Table 2, Table 3) is required, provided trainees can rotate to train with an IC (in the same or different institution) with the necessary expertise.
Ideally, the number of trainers (full-time equivalent) should match or exceed the number of trainees. Delivery of the curriculum may be facilitated by a structure that includes a director of training (national/regional), a cath lab director (or supervisor), a training mentor (or educational mentor), and multiple clinical trainers (or clinical mentors).
The training mentor (or someone else involved in the organisation of training) should be responsible for organising the training programme in interventional cardiology, coordinating external rotations to referral centres, attendance at courses and congresses, and organising structured learning. It is necessary that both trainee and training mentors be subject to periodic assessment.
Number of trainers and their expertise
At least two trainers (supervisors) must be available, with more than five years’ experience dedicated to interventional cardiology as their main clinical activity. These trainers should be members of the permanent staff and should be able to deliver the procedural skills associated with levels of competence III, IV and V in the learning objectives (Table 2, Table 3).
In advanced centres, trainers should have experience of more than five years performing advanced heart interventions.
Trainers without personal expertise in these additional skills described in the learning objective (levels of competence I and II, Table 2, Table 3) should make them available to trainees through a cooperation programme with other trainers (or other institutions) who will deliver the formal training on these techniques. A similar five years of experience is required for the trainers delivering training on each one of those additional procedural skills.
The cath lab director must be responsible for the interventional unit and should ensure that the trainee fulfils his/her learning objectives. The training mentor must also ensure that the trainee attends the formal training courses and is involved in the research and educational activities of the department.
Acknowledgments
Conflict of interest statement
A. Baumbach received institutional research support from Abbott Vascular, consultation and speaker fees from AstraZeneca, Sinomed, MicroPort, Abbott Vascular, Cardinal Health, KSH, and Medtronic. R. Estevez-Loureiro reports grants and personal fees from Abbott Vascular and personal fees from Boston Scientific, outside the submitted work. A. Geppert reports lecture fees from Medtronic, Abbott and Abiomed, consulting fees from Abbott and Abiomed, congress grants from Asahi and Terumo, outside the submitted work. J. Kefer reports proctorship and speaker fees from Medtronic and Abbott, and speaker fees from Servier. D. Milasinovic reports personal fees from Abbot, Biosensors, Terumo, AstraZeneca and Sanofi, outside the submitted work. D. Muir is a proctor and advisory board member for Abbott Vascular, and received proctor, advisory board and speaker fees from Edwards Lifesciences. A.S. Petronio received proctor and advisory board fees from Abbott Vascular, and received proctor, advisory board and speaker fees from Edwards Lifesciences. G. Pires-Morais received speaker fees from Abbott Vascular. S. Pyxaras received consultancy fees from Abiomed and Boston Scientific and proctor fees from Boston Scientific. R. Parma received speaker fees from Boston Scientific, Edwards Lifesciences and Medtronic. F. Saia reports personal fees from Abbott Vascular, Boston Scientific, Edwards, Medtronic, Biotronik, Amgen, AstraZeneca, Daiichi Sankyo, Bayer and Boehringer-Ingelheim, outside the submitted work. N. Van Mieghem reports advisor fees from PulseCath BV and Abiomed. S. Windecker reports grants from Abbott, Amgen, BMS, Bayer, Boston Scientific, Biotronik, Cardinal Health, CSL Behring, Daiichi Sankyo, Edwards Lifesciences, Johnson and Johnson, Medtronic, Quebert, Polares, Sanofi and Terumo, outside the submitted work. E. Van Belle reports personal fees from HeartFlow and Philips, outside the submitted work. The other authors have no conflicts of interest to declare.
Contributor Information
Eric Van Belle, CHRU Lille, Institut Coeur-Poumon, Department of Cardiology, Lille, France.
Rui Campante Teles, Hospital de Santa Cruz CHLO, Carnaxide, Portugal; CEDOC, Nova Medical School, Lisboa, Portugal.
Stylianos A. Pyxaras, Medizinische Klinik I, Landshut-Achdorf Hospital, Landshut, Germany.
Oliver Kalpak, University Cardiology Clinic, Skopje, Macedonia.
Thomas W. Johnson, Bristol Heart Institute, Bristol, United Kingdom.
Israel Barbash, Leviev Heart Center, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Giuseppe De Luca, AOU Maggiore della Carità, Eastern Piedmont University, Novara, Italy.
Jorgo Kostov, University Cardiology Clinic, Skopje, Macedonia.
Radoslaw Parma, Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
Flavien Vincent, CHRU Lille, Institut Coeur-Poumon, Department of Cardiology, Lille, France.
Salvatore Brugaletta, Hospital Clinic, Cardiovascular Clinic Institute, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Nicolas Debry, CHRU Lille, Institut Coeur-Poumon, Department of Cardiology, Lille, France.
Gabor Toth, University Heart Center Graz, Medical University Graz, Graz, Austria.
Ziyad Ghazzal, American University of Beirut Faculty of Medicine and Medical Center, Lebanon.
Pierre Deharo, Hopital la Timone, Marseille, France.
Dejan Milasinovic, Clinical Center of Serbia, Department of Cardiology, Belgrade, Serbia.
Klaus Kaspar, LKH Hochsteiermark/Bruck, Bruck / Mur, Austria.
Francesco Saia, Cardio-Thoraco-Vascular Department University Hospital of Bologna, Policlinico S. Orsola - Malpighi (Pav. 23), Bologna, Italy.
Josepa Mauri Ferre, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Jürgen Kammler, Med Campus III., Kepler University Hospital Linz, Faculty of Medicine, Johannes Kepler University Linz, Linz, Austria.
Douglas Muir, The James Cook University Hospital, Middlesbrough, United Kingdom.
Stephen O'Connor, St. James's Hospital, Dublin, Ireland.
Julinda Mehilli, Med. Klinik und Poliklinik I, Klinikum der Universitaet, Ludwig-Maximilian University, Munich Heart Alliance at DZHK, Munich, Germany.
Holger Thiele, Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology and Leipzig Heart Institute, Leipzig, Germany.
Daniel Weilenmann, Department of Cardiology, Kantonsspital St. Gallen, Gallen, Switzerland.
Nils Witt, Department of clinical science and education, Karolinska Institute, Division of cardiology Södersjukhuset, Stockholm, Sweden.
Francis Joshi, Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Rajesh K. K. Kharbanda, Oxford University Hospitals NHS Trust and Oxford NIHR Biomedical Centre.
Zsolt Piroth, Hungarian Institute of Cardiology, Haller street, Budapest, Hungary.
Wojciech Wojakowski, Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
Alexander Geppert, Wilhelminenhospital Vienna, Vienna, Austria.
Giuseppe Di Gioia, Cardiovascular Center OLV Hospital, Aalst, Belgium.
Gustavo Pires-Morais, Cardiovascular Intervention Unit, Department of Cardiology, Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal.
Anna Petronio, Cardiothoracic and Vascular Dpt. AOUP,University of Pisa, Italy.
Rodrigo Estévez-Loureiro, University Hospital Puerta de Hierro-Majadahonda, Madrid Spain.
Zoltan Ruzsa, Semmelweis University, Heart and Vascular Center, Budapest, Hungary.
Joelle Kefer, Cliniques universitaires Saint-Luc, Bruxelles, Belgium.
Vijay Kunadian, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University and Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom.
Nicolas Van Mieghem, Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
Stephan Windecker, Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Andreas Baumbach, Queen Mary University of London, Barts Heart Centre, London, United Kingdom.
Michael Haude, Med. Klinik I, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany.
Dariusz Dudek, Jagiellonian University Medical College in Poland, Krakow, Poland.
References
- Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–77. doi: 10.1093/eurheartj/ehx393. [DOI] [PubMed] [Google Scholar]
- Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91. doi: 10.1093/eurheartj/ehx391. [DOI] [PubMed] [Google Scholar]
- Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–77. doi: 10.1093/eurheartj/ehz425. [DOI] [PubMed] [Google Scholar]
- Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165. doi: 10.1093/eurheartj/ehy394. [DOI] [PubMed] [Google Scholar]
- Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS, Bhindi R, Lehman SJ, Walters D, Sapontis J, Janssens L, Vrints CJ, Khashaba A, Laine M, Van Belle E, Krackhardt F, Bojara W, Going O, Härle T, Indolfi C, Niccoli G, Ribichini F, Tanaka N, Yokoi H, Takashima H, Kikuta Y, Erglis A, Vinhas H, Canas Silva P, Baptista SB, Alghamdi A, Hellig F, Koo BK, Nam CW, Shin ES, Doh JH, Brugaletta S, Alegria-Barrero E, Meuwissen M, Piek JJ, van Royen N, Sezer M, Di Mario C, Gerber RT, Malik IS, Sharp ASP, Talwar S, Tang K, Samady H, Altman J, Seto AH, Singh J, Jeremias A, Matsuo H, Kharbanda RK, Patel MR, Serruys P, Escaned J. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017;376:1824–34. doi: 10.1056/NEJMoa1700445. [DOI] [PubMed] [Google Scholar]
- Van Belle E, Gil R, Klauss V, Balghith M, Meuwissen M, Clerc J, Witzenbichler B, Cercek M, Vlachojannis M, Lang I, Commeau P, Vincent F, Testa L, Wasek W, Debry N, Kische S, Gabrielli G, Sardella G. Impact of Routine Invasive Physiology at Time of Angiography in Patients With Multivessel Coronary Artery Disease on Reclassification of Revascularization Strategy: Results From the DEFINE REAL Study. JACC Cardiovasc Interv. 2018;11:354–65. doi: 10.1016/j.jcin.2017.11.030. [DOI] [PubMed] [Google Scholar]
- Danchin N, Coste P, Ferrieres J, Steg PG, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, Sans P, Charbonnier B, Eltchaninoff H, Gueret P, Khalife K, Asseman P, Puel J, Goldstein P, Cambou JP, Simon T FAST-MI Investigators. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation. 2008;118:268–76. doi: 10.1161/CIRCULATIONAHA.107.762765. [DOI] [PubMed] [Google Scholar]
- Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98. doi: 10.1056/NEJMoa1103510. [DOI] [PubMed] [Google Scholar]
- Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U CULPRIT-SHOCK Investigators. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med. 2017;377:2419–32. doi: 10.1056/NEJMoa1710261. [DOI] [PubMed] [Google Scholar]
- Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Lycklama à Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van Rooij WJ, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog HM, Gerrits DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van der Lugt A, van Oostenbrugge RJ, Majoie CB, Dippel DW MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20. doi: 10.1056/NEJMoa1411587. [DOI] [PubMed] [Google Scholar]
- Xaplanteris P, Fournier S, Keulards DCJ, Adjedj J, Ciccarelli G, Milkas A, Pellicano M, Veer M, Barbato E, Pijls NHJ, Bruyne BD. Catheter-based measurements of absolute coronary blood flow and microvascular resistance. Circ Cardiovasc Interv. 2018;11:e006194. doi: 10.1161/CIRCINTERVENTIONS.117.006194. [DOI] [PubMed] [Google Scholar]
- Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jimenez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41:543–603. doi: 10.1093/eurheartj/ehz405. [DOI] [PubMed] [Google Scholar]
- Di Mario C, Di Sciascio G, Dubois-Randé JL, Michels R, Mills P. Curriculum and syllabus for Interventional Cardiology subspecialty training in Europe. EuroIntervention. 2006;2:31–6. [PubMed] [Google Scholar]
- Gillebert TC, Brooks N, Fontes-Carvalho R, Fras Z, Gueret P, Lopez-Sendon J, Salvador MJ, van den Brink RB, Smiseth OA, Griebenow R. ESC core curriculum for the general cardiologist (2013). Eur Heart J. 2013;34:2381–411. doi: 10.1093/eurheartj/eht177. [DOI] [PubMed] [Google Scholar]
- Bagai A, O'Brien S, Al Lawati H, Goyal P, Ball W, Grantcharov T, Fam N. Mentored simulation training improves procedural skills in cardiac catheterization: a randomized, controlled pilot study. Circ Cardiovasc Interv. 2012;5:672–9. doi: 10.1161/CIRCINTERVENTIONS.112.970772. [DOI] [PubMed] [Google Scholar]
- Schimmel DR, Sweis R, Cohen ER, Davidson C, Wayne DB. Targeting clinical outcomes: Endovascular simulation improves diagnostic coronary angiography skills. Catheter Cardiovasc Interv. 2016;87:383–8. doi: 10.1002/ccd.26089. [DOI] [PubMed] [Google Scholar]
- Holmes DR Jr, Rich JB, Zoghbi WA, Mack MJ. The heart team of cardiovascular care. J Am Coll Cardiol. 2013;61:903–7. doi: 10.1016/j.jacc.2012.08.1034. [DOI] [PubMed] [Google Scholar]
- Olle Ten Cate. Nuts and Bolts of Entrustable Professional Activities. J Grad Med Educ. 2013;5:157–8. doi: 10.4300/JGME-D-12-00380.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Räber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, Radu MD, Joner M, Yu B, Jia H, Meneveau N, de la Torre Hernandez JM, Escaned J, Hill J, Prati F, Colombo A, Di Mario C, Regar E, Capodanno D, Wijns W, Byrne RA, Guagliumi G ESC Scientific Document Group. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2018;39:3281–300. doi: 10.1093/eurheartj/ehy285. [DOI] [PubMed] [Google Scholar]
- Johnson TW, Räber L, Di Mario C, Bourantas CV, Jia H, Mattesini A, Gonzalo N, de la Torre Hernandez JM, Prati F, Koskinas KC, Joner M, Radu MD, Erlinge D, Regar E, Kunadian V, Maehara A, Byrne RA, Capodanno D, Akasaka T, Wijns W, Mintz GS, Guagliumi G. Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2019;40:2566–84. doi: 10.1093/eurheartj/ehz332. [DOI] [PubMed] [Google Scholar]
- Byrne RA, Stefanini GG, Capodanno D, Onuma Y, Baumbach A, Escaned J, Haude M, James S, Joner M, Jüni P, Kastrati A, Oktay S, Wijns W, Serruys PW, Windecker S. Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. EuroIntervention. 2018;13:1574–86. doi: 10.4244/EIJ20170912-01. [DOI] [PubMed] [Google Scholar]
- Brilakis ES, Mashayekhi K, Tsuchikane E, Abi Rafeh N, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Bhindi R, Boudou N, Boukhris M, Bozinovic NZ, Bryniarski L, Bufe A, Buller CE, Burke MN, Büttner HJ, Cardoso P, Carlino M, Christiansen EH, Colombo A, Croce K, Damas de Los Santos F, De Martini T, Dens J, Di Mario C, Dou K, Egred M, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Ge J, Goel PK, Goktekin O, Grancini L, Grantham JA, Hanratty C, Harb S, Harding SA, Henriques JPS, Hill JM, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Laanmets P, Lamelas P, Lee SW, Lefevre T, Li Y, Lim ST, Lo S, Lombardi W, McEntegart M, Munawar M, Navarro Lecaro JA, Ngo HM, Nicholson W, Olivecrona GK, Padilla L, Postu M, Quadros A, Quesada FH, Prakasa Rao VS, Reifart N, Saghatelyan M, Santiago R, Sianos G, Smith E, C Spratt J, Stone GW, Strange JW, Tammam K, Ungi I, Vo M, Vu VH, Walsh S, Werner GS, Wollmuth JR, Wu EB, Wyman RM, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q, Rinfret S. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention. Circulation. 2019;140:420–33. doi: 10.1161/CIRCULATIONAHA.119.039797. [DOI] [PubMed] [Google Scholar]
- Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Généreux P, Pershad A, Alu MC, Webb JG, Smith CR PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019;380:1695–705. doi: 10.1056/NEJMoa1814052. [DOI] [PubMed] [Google Scholar]
- Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ COAPT Investigators. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med. 2018;379:2307–18. doi: 10.1056/NEJMoa1806640. [DOI] [PubMed] [Google Scholar]